Navigation Links
Auxilium Pharmaceuticals, Inc. Raises $50 Million In Additional Financing
Date:9/20/2013

ticipate," "intend," "plan," "could," "estimate," "project," "will," and "target."  Our forward-looking statements convey management's expectations, beliefs, plans and objectives regarding future performance of the Company and are based upon preliminary information and management assumptions.  No specific assurances can be given regarding the potential use of the proceeds from the additional financing, the Company's ability to maximize its existing portfolio or the Company's ability to bring in additional products. While the Company may elect to update the forward-looking statements made in this news release in the future, the Company specifically disclaims any obligation to do so.  Such forward-looking statements are subject to a wide range of risks and uncertainties that could cause results to differ in material respects, including those relating to product development, revenue, expense and earnings expectations, intellectual property rights, results and timing of clinical trials, success of marketing efforts, the need for additional research and testing, and the timing and content of decisions made by regulatory authorities, including the U.S. Food and Drug Administration, and those risks discussed in our reports on file with the Securities and Exchange Commission (the "SEC").  Our SEC filings may be accessed electronically by means of the SEC's home page on the Internet at http://www.sec.gov or by means of the Company's home page on the Internet at http://www.auxilium.com under the heading "For Investors - SEC Filings."  There may be additional risks that the Company does not presently know or that the Company currently believes are immaterial which could also cause actual results to differ from those contained in the forward-looking statements.AUXILIUM CONTACTS: James E. Fickenscher / CFO

Nichol Ochsner/ Senior Director, IR  Auxilium Pharmaceuticals, In
'/>"/>

SOURCE Auxilium Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Auxilium Pharmaceuticals, Inc. To Present At The Stifel Nicolaus Healthcare Conference
2. Auxilium Pharmaceuticals, Inc. to Present at the Morgan Stanley Global Healthcare Conference
3. Auxilium Pharmaceuticals, Inc. to Present at the Canaccord Genuity Growth Conference
4. Auxilium Pharmaceuticals, Inc, Announces Second Quarter 2013 Financial Results
5. Auxilium Pharmaceuticals to Announce Second Quarter 2013 Results and Conduct Conference Call on Thursday, August 1, 2013
6. New Breakthroughs Allow Companies to Expand their Reach - Research Report on Perrigo, Auxilium, Actavis, Mylan, and Salix
7. Auxilium Pharmaceuticals, Inc. To Present At The Jefferies 2013 Healthcare Conference
8. Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference
9. Auxilium Pharmaceuticals, Inc. To Present At The UBS Global Health Care Conference
10. Auxilium Pharmaceuticals, Inc. To Present At The Bank Of America Merrill Lynch 2013 Health Care Conference
11. Auxilium Pharmaceuticals Completes Acquisition Of Actient Holdings LLC To Create A Leading Urology Franchise With A Diversified Product Portfolio And Strong Growth Profile
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... 22, 2014 NxStage Medical, Inc. (NASDAQ: ... dialysis products, announced today that the U.S. Food ... One™ to perform hemodialysis overnight while the patient ... hemodialysis. NxStage,s® System One is the first and ... this indication. Home nocturnal hemodialysis ...
(Date:12/22/2014)... 22, 2014   TRU-D SmartUVC LLC, producers ... robot, announced today that the General Services Administration has ... 2019.   This newly formed agreement will ... of government purchasers, including Department of Veteran Affairs and ... Security contacts purchasing solutions for the Ebola effort in ...
(Date:12/22/2014)... , Dec. 22, 2014 Cyberonics, Inc. (NASDAQ: ... the treatment and management of epilepsy, today announced it will ... Conference on Wednesday, January 14, 2015, in San ... President and Chief Executive Officer, will speak at 11:00 AM ... be accessed by clicking on the Investor Relations link on ...
Breaking Medicine Technology:NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 2NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 3TRU-D SmartUVC LLC Awarded General Services Administration Contract to Expand Government Customer Base 2
... March 5, 2012 Medical Care Technologies Inc. ... Special Meeting of Shareholders of the Company,s common stock held ... for lack of quorum. The adjourned Special Meeting will occur ... to provide time for the shareholders to ensure that their ...
... Wash., March 5, 2012  SCOLR Pharma, Inc. (OTCQB: SCLR) ... product information and "where to buy" details for their ... available retailers can be found on www.scolr.com ... page can be reached from the home page or ...
Cached Medicine Technology:Medical Care Technologies Inc. Announces Adjournment of Special Meeting 2Medical Care Technologies Inc. Announces Adjournment of Special Meeting 3SCOLR Pharma, Inc. Provides Product Information on Website 2
(Date:12/24/2014)... December 25, 2014 Epigenetics finds applications ... research, including oncology, drug discovery, developmental biology, and research ... as one of the most widely used techniques for ... GLOBOCAN, the prevalence of cancer is rapidly growing worldwide. ... 8.2 million cancer deaths, and 32.6 million people living ...
(Date:12/24/2014)... 24, 2014 Dr. Vu Ho, a ... of his practice and med-spa with the addition of ... list of cosmetic treatments and services. , “Silk Peel ... skin,” says Dr. Ho. “As a result it can ... wrinkles, sun spots, discolorations or blemishes.” , Similar to ...
(Date:12/24/2014)... 24, 2014 Mike Billings , ... with Derek Fenwick, PT, MBA, GCS, Director of ... stem from the passing of the Improving Medicare ... In this taping of the Infinicast, the two leaders ... the Social Security Act to standardize post-acute assessment data ...
(Date:12/24/2014)... 24, 2014 (HealthDay News) -- A new, injectable weight-loss ... Drug Administration. The agency on Tuesday approved Saxenda ... who are overweight and have at least one weight-related ... diabetes or high cholesterol. Patients taking the drug, ... diet and exercise regularly, the FDA noted. "Obesity ...
(Date:12/24/2014)... Steven Reinberg HealthDay Reporter ... from the American Diabetes Association (ADA) call for giving the ... to help prevent heart disease. These new standards bring ... and American Heart Association, which also recommend giving low- or ... including people with diabetes. "We agree that the decision ...
Breaking Medicine News(10 mins):Health News:Global Epigenetics Market Was Valued at $413.24 Million in 2014 - New Research Report by MarketsandMarkets 2Health News:Global Epigenetics Market Was Valued at $413.24 Million in 2014 - New Research Report by MarketsandMarkets 3Health News:Dr. Vu Ho Expands Facial Plastic Surgery Practice to Include New Skin Care Treatment 2Health News:Latest Episode of Infinicast Features Infinity Rehab President Discussing IMPACT Act of 2014 and Changes for Post-Acute Therapy Providers in 2015 2Health News:FDA Approves New Weight-Loss Drug 2Health News:FDA Approves New Weight-Loss Drug 3Health News:Nearly All Diabetics Should Be on Cholesterol-Lowering Drugs: Experts 2Health News:Nearly All Diabetics Should Be on Cholesterol-Lowering Drugs: Experts 3
... Aug. 13 As the debate over health care reform heats up, ... district has been, well, blunted. , , The billboard ... Blunt has taken $556,682 in contributions from the insurance industry. Is that ... , USAction and its Missouri affiliate, Missouri Progressive Vote Coalition, ...
... sexual assault and seeking help is difficult for anyone, but ... (LGBTQ) the thought of reporting a crime may well be ... a study in Oregon. The study, appearing in the ... found that 94 percent of respondents -- most of them ...
... , , , ... care industry moves from paper-based to electronic record-keeping, protecting confidential ... issue, Verizon is unveiling two new capabilities designed to help ... clinics, physicians, insurers and patients. , , ...
... , TORONTO, Aug. 13 /PRNewswire-FirstCall/ - Patheon Inc. (TSX: ... services to the global pharmaceutical industry, announced today that ... on Monday, September 14, 2009. , In conjunction with ... financial analysts on Monday, September 14, 2009 at 10:00 ...
... TOSU, SAGA, Japan, Aug. 13 Hisamitsu Pharmaceutical Co., Inc. ... announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust ... p.m., New York City time, on August 12, 2009, with respect ... NOVN ). , , ...
... Medical Research Council (MRC) scientists have made an important advance ... to die. The work may help scientists to eventually develop ... occur when cell death goes wrong. The research, published ... 14 August 2009) was carried out by a team of ...
Cached Medicine News:Health News:Blunted by Roy Blunt: The Billboard the Congressman Doesn't Want You to See 2Health News:Little safe haven for sexually assaulted LGBTQ victims 2Health News:Little safe haven for sexually assaulted LGBTQ victims 3Health News:Verizon Introduces New IT Security Capabilities for Health Care Industry 2Health News:Verizon Introduces New IT Security Capabilities for Health Care Industry 3Health News:Verizon Introduces New IT Security Capabilities for Health Care Industry 4Health News:Patheon Announces Date of Third Quarter 2009 Financial Results Release, Conference Call and Webcast 2Health News:Hisamitsu Pharmaceutical Announces Expiration of HSR Waiting Period for Its Proposed Acquisition of Noven Pharmaceuticals 2Health News:MRC scientists advance understanding of cell death 2
... This Sarmiento style Patella-Tendon-Bearing brace is designed ... the tibia and fibula. The tibial crest ... intra medullary nailing and removal of internal ... movement of joints above and below the ...
Designed as an excellent form of primary suspension...
... Bird and Cronin, Inc. ... of Patient Footwear, Orthopedic ... Care Products. Our products ... quality and available in ...
... This lightweight orthosis is designed to ... joint while allowing unobstructed motion of ... more custom fit the splint may ... formed using a heat gun. One ...
Medicine Products: